Trials / Conditions / Candidiasis, Invasive

Candidiasis, Invasive

9 registered clinical trials studyying Candidiasis, Invasive — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia an NCT05421858	Basilea Pharmaceutica	Phase 3
Terminated	A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin NCT05178862	Scynexis, Inc.	Phase 3
Completed	Early Identification of Candida in Intra-abdominal Candidiasis NCT05264571	Central Hospital, Nancy, France	—
Completed	Peritoneal 1.3-ß-D-glucan for the Diagnosis of Intra-abdominal Candidiasis in Critically Ill Patients (pBDG2) NCT03997929	Central Hospital, Nancy, France	—
Completed	Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidia NCT03363841	Scynexis, Inc.	Phase 3
Completed	Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candid NCT02244606	Scynexis, Inc.	Phase 2
Terminated	Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invas NCT01945281	Merck Sharp & Dohme LLC	Phase 2
Completed	A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus I NCT01165320	Merck Sharp & Dohme LLC	Phase 2
Completed	Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections NCT00413218	Astellas Pharma Inc	Phase 3